Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 52,293 | 45,602 | 41,457 | 57,476 | 51,500 |
| Cost of Goods | 24,742 | 21,735 | 21,300 | 23,824 | 22,495 |
| Gross Profit | 27,551 | 23,867 | 20,157 | 33,652 | 29,005 |
| Operating Expenses | 37,485 | 35,226 | 35,432 | 31,490 | 33,748 |
| Operating Income | -9,192 | -10,624 | -14,975 | 2,986 | -4,248 |
| Interest Expense | 494 | 414 | 291 | -5,933 | 119 |
| Other Income | 1,917 | 4,263 | 4,000 | 1,403 | 4,524 |
| Pre-tax Income | -7,769 | -6,775 | -11,266 | 10,322 | 157 |
| Income Tax | -2,291 | -1,192 | 136 | 680 | -784 |
| Net Income Continuous | -5,478 | -5,583 | -11,402 | 9,642 | 941 |
| Net Income | $-5,478 | $-5,583 | $-11,402 | $9,642 | $941 |
| EPS Basic Total Ops | -0.04 | -0.04 | -0.09 | 0.07 | 0.01 |
| EPS Basic Continuous Ops | -0.04 | -0.04 | -0.09 | 0.07 | 0.01 |
| EPS Diluted Total Ops | -0.04 | -0.04 | -0.09 | 0.07 | 0.01 |
| EPS Diluted Continuous Ops | -0.04 | -0.04 | -0.09 | 0.07 | 0.01 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.04 | -0.09 | 0.07 | 0.01 |
| EBITDA(a) | $-6,132 | $-7,636 | $-12,091 | $5,727 | $-1,439 |